•$Verve Therapeutics (VERV.US)$-19.3% (priced upsized underwritten public offering of 8,333,334 shares of common stock at $27.00 per share for total gross proceeds of ~$225.0mln)
•$Carnival (CCL.US)$-12.4% (prices offering of 102,139,621 shares of common stock at $9.95 per share)
•$Arbutus Biopharma (ABUS.US)$-6.6% (provides update on Phase 2A combination trial with AB-729 and a Capsid Inhibitor)
•$Coinbase (COIN.US)$-5.5%(on news thatTSLAconverted 75% of its Bitcoin purchases into fiat currency)